Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Central Line Securement Device: Line Complications and Quality of Life in the Pediatric Population as Compared to Traditional Securement Device

NCT04522778 is registered in ClinicalTrials.gov with Ryan St. Pierre-Hetz as lead sponsor.

NCT NCT04522778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04522778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Central Line Securement Device: Line Complications and Quality of Life in the Pediatric Population as Compared to Traditional Securement Device
Lead sponsor
Ryan St. Pierre-Hetz
Phase
Not applicable
Overall status
Terminated
Start date
November 5, 2020
Completion date
May 1, 2023
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central line complication, central line infection, central line sepsis, central line-associated infection, pediatric disorder, quality of life, short gut syndrome